Author

Aymeric Leveau

Eligo Bioscience (France)ORCID 0000-0002-1312-9212Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Approach:experimental assay· 1

Frequent Co-Authors

Andreas K. BrödeliD· 1 shared Antoine L. Decrulle· 1 shared Antonina O. KrawczykiD· 1 shared Aurélie Grienenberger· 1 shared Benjamin Buhot· 1 shared Camila Barbosa Bramorski· 1 shared Chloé Poquet· 1 shared Dalila Spadoni· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSynthetic Biology

Andreas K. BrödelORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Synthetic BiologybioRxivPreprintFeb 28, 2025

Treatment of STEC infection via CRISPR-Cas targeted cleavage of the Shiga toxin gene in animal models

Matthieu Galtier, Antonina O. Krawczyk, Fabien J. Fuche…·Jesús Fernández-Rodríguez

This paper develops a CRISPR-based therapy targeting Shiga toxin genes in STEC infections, showing efficacy in reducing bacterial load and mitigating disease in animal models.

4 citations

E. coliexperimental assay

𝕏 PostBluesky